ImClone Investigational Site — Boston, Massachusetts

ImClone Investigational Site is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

ImClone Investigational Site has participated in 13 clinical trials.

Therapeutic areas: Gastrointestinal Stromal Tumor (GIST), Metastatic Renal Cell Carcinoma, Gastric Cancer.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ImClone Investigational Site?

ImClone Investigational Site has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ImClone Investigational Site conducted?

ImClone Investigational Site has 13 clinical trials on record. Their work covers Gastrointestinal Stromal Tumor (GIST), Metastatic Renal Cell Carcinoma, Gastric Cancer.

Is ImClone Investigational Site accredited by Crixeo Health?

Yes — ImClone Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about ImClone Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.